INSURE技术联合布地奈德治疗极低出生体重儿呼吸窘迫综合征对支气管肺发育不良发生率的影响

doi:10.11852/zgetbjzz2019-1452

中国儿童保健杂志 ›› 2020, Vol. 28 ›› Issue (8): 921-924.DOI: 10.11852/zgetbjzz2019-1452

INSURE技术联合布地奈德治疗极低出生体重儿呼吸窘迫综合征对支气管肺发育不良发生率的影响

张慧, 马源培, 武慧, 朴梅花, 韩彤妍

北京大学第三医院, 北京 100191

收稿日期:2019-12-18 修回日期:2020-02-11 发布日期:2020-08-10 出版日期:2020-08-10
通讯作者: 韩彤妍, E-mail:tongyanhan@qq.com
作者简介:张慧(1988-), 女, 河南人, 主治医师, 博士学位, 主要研究方向为新生儿和儿童内分泌

Effect of INSURE strategy in combination with budesonide on the incidence of bronchopulmonary dysplasiaduring the treatment of respiratory distress syndrome in very low birth weight

ZHANG Hui, MA Yuan-pei, WU Hui, PIAO Mei-hua, HAN Tong-yan

Department of Pediatrics, Peking University Third Hospital, Beijing 100191, China

Received:2019-12-18 Revised:2020-02-11 Online:2020-08-10 Published:2020-08-10
Contact: HAN Tong-yan, E-mail:tongyanhan@qq.com

摘要/Abstract

摘要： 目的分析INSURE技术联合布地奈德治疗极低出生体重儿呼吸窘迫综合征(RDS)对支气管肺发育不良(BPD)发生率的影响, 为降低BPD发生率的临床治疗提供科学依据。方法 1)选取于2014年1月—2018年12月出生后1 h内北京大学第三医院NICU收治的胎龄＜32 周、出生体重1 000～1 500 g、诊断为RDS的患儿83例, 分为改良组35例(INSURE技术联合布地奈德, 即气管插管-注入肺表面活性物质联合布地奈德-拔管后经鼻持续正压通气)和常规组48例(气管内滴入肺表面活性物质后连接有创机械通气):2)设计临床调查表, 记录一般资料、BPD及其他合并症发生率、转归等。结果 1)改良组给药后6 h PO₂高于常规组, 呼吸机和总用氧时间均较常规组短, 差异有统计学意义(t=2.571、3.633、3.484, P＜0.05);2)改良组BPD、动脉导管未闭发生率均低于常规组, 差异有统计学意义(χ²=3.886、3.920, P＜0.05), 其他合并症发生率和存活率差异均无统计学意义(P＞0.05)。结论 INSURE技术联合布地奈德早期可明显改善氧合指数, 缩短呼吸机和总用氧时间, 有效降低极低出生体重儿BPD的发生率, 同时也明显降低动脉导管未闭的发生率, 短期内未增加其他疾病及死亡的风险, 值得临床进一步研究及推广。

关键词: 支气管肺发育不良, INSURE技术, 布地奈德, 极低出生体重儿, 呼吸窘迫综合征

Abstract: Objective To analyze the effect of INSURE strategy in combination with budesonide on the incidence of bronchopulmonary dysplasia(BPD) during the treatment of respiratory distress syndrome in very low birth weight, in order to provide scientific basis for clinical treatment to reduce the incidence of BPD. Methods 1) A total of 83 neonates diagnosed with RDS admitted to Peking University Third Hospital within 1 h after birth from January 2014 to December 2018, whose gestational age was less than 32 weeks and birth weight was from 1 000 to 1 500 g, were selected in this study, and were divided into the modified group with 35 cases (intubation-surfactant and budesonide-extubation) and conventional group with 48 cases (intratracheal administration of surfactant and mechanical ventilation).2) A clinical questionnaire was designed to collect general information, incidences of BPD and other complications, outcomes and so on. Results 1) PO₂ in the modified group was higher than that in the conventional group at 6 h after administration, and both ventilator and total oxygen use time were significantly shorter than those in the conventional group (t=2.571, 3.633, 3.484, P＜0.05).2) The incidence of BPD and patent ductus arteriosus in the modified group was significantly lower than those in the conventional group (χ²=3.886, 3.920, P＜0.05).But there were no statistically significant differences on the incidence of other complications and survival rate between the two groups(P＞0.05). Conclusions INSURE strategy in combination with budesonide can improve oxygenation in early stage, shorten ventilator and total oxygen use time, significantly reduce the incidence of BPD, and also reduce the incidence of patent ductus arteriosus, which does not increase the risk of other diseases and death in the short term.Therefore, further researches are warranted so as to promote its application on clinical practice.

Key words: bronchopulmonary dysplasia, intubation-surfactant-extubation, budesonide, very low birth weight infant, respiratory distress syndrome

中图分类号:

R722.1

张慧, 马源培, 武慧, 朴梅花, 韩彤妍. INSURE技术联合布地奈德治疗极低出生体重儿呼吸窘迫综合征对支气管肺发育不良发生率的影响[J]. 中国儿童保健杂志, 2020, 28(8): 921-924.

ZHANG Hui, MA Yuan-pei, WU Hui, PIAO Mei-hua, HAN Tong-yan. Effect of INSURE strategy in combination with budesonide on the incidence of bronchopulmonary dysplasiaduring the treatment of respiratory distress syndrome in very low birth weight[J]. journal1, 2020, 28(8): 921-924.

参考文献

[1] 邵肖梅, 叶鸿瑁, 丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社, 2011:395-887.
[2] Chun J, Sung SI, Ho YH, et al.Prophylactic versus early rescue surfactant treatment in preterm infants born at less than 30 weeks gestation or with birth weight less than or Equal 1 250 grams[J].J Korean Med Sci, 2017, 32(8):1288-1294.
[3] 邓黎静, 彭华保, 龚晓琴.布地奈德联合肺表面活性物质治疗重症呼吸窘迫综合征对支气管肺发育不良的影响[J].中国新生儿科杂志, 2017, 32(5):361-364.
[4] Sadeghnia A, Beheshti BK, Mohammadizadeh M.The effect of inhaled budesonide on the prevention of chronic lung disease in premature neonates with respiratory distress syndrome[J].Int J Prev Med, 2018, 9:15.
[5] Malavolti AM, Bassler D, Arlettazmieth R, et al.Bronchopulmonary dysplasia-impact of severity and timing of diagnosis on neurodevelopment of preterm infants:a retrospective cohort study[J].Bmj Paediatrics Open, 2018, 2(1):e000165.
[6] Vom HM, Prenzel F, Uhlig HH, et al.Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia:a case-control follow-up at school age[J].J Pediatr, 2014, 164(1):40-45.
[7] Nakhshab M, Tajbakhsh M, Khani S, et al.Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome:a randomized controlled study[J].Pediatr Neonatol, 2015, 56(2):88-94.
[8] Dunn MS, Kaempf J, de Klerk A, et al.Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates[J].Pediatrics, 2011, 128(5):e1069-e1076.
[9] Bassler D.Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia[J].Neonatology, 2015, 107(4):358-359.
[10] 陈奕江, 张水堂, 杨润娜.生后7天内气道内应用布地奈德对早产儿支气管肺发育不良发生率影响的系统评价和Meta分析[J].中国循证儿科杂志, 2016, 11(4):258-264.
[11] Yang CF, Lin CH, Chiou SY, et a1.Intratracheal budesonide supplementation in addition to surfactant improves pulmonary outcome in surfactant-depleted newborn piglets[J].Pediatr Pulmonol, 2013, 48(2):151-159.
[12] Yeh TF, Lin HC, Chang CH, et a1.Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants:a pilot Study[J].Pediatrics, 2008, 121(5):e1310-e1318.
[13] Kuo HT, Lin HC, Tsai CH, et al.A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants[J].J Pediatr, 2010, 156(4):537-541.
[14] Naseh A, Yekta BG.INSURE method (INtubation-SURfactant Extubation) in early and late premature neonates with respiratory distress:factors affecting the outcome and survival rate[J].Turk J Pediatr, 2014, 56(3):232-237.
[15] 李玮, 徐东, 常立文.INSURE策略在极/超早产儿中应用失败的危险因素分析[J].中华新生儿科杂志, 2017, 32(5):325-330.

INSURE技术联合布地奈德治疗极低出生体重儿呼吸窘迫综合征对支气管肺发育不良发生率的影响

Effect of INSURE strategy in combination with budesonide on the incidence of bronchopulmonary dysplasiaduring the treatment of respiratory distress syndrome in very low birth weight

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	夏正龙, 宋燕燕. 支气管肺发育不良早产儿神经发育研究[J]. 中国儿童保健杂志, 2023, 31(4): 390-394.
[2]	李静兰, 孙文强, 朱雪萍. 早产儿支气管肺发育不良相关预测模型研究[J]. 中国儿童保健杂志, 2023, 31(4): 395-398.
[3]	王惠萍, 王莉, 高琼, 白铂亮, 马颖君. 极低出生体重坏死性小肠结肠炎患儿体格及神经发育的研究[J]. 中国儿童保健杂志, 2023, 31(1): 96-100.
[4]	林洁, 段山. 支气管肺发育不良基因表达调控异常研究进展[J]. 中国儿童保健杂志, 2022, 30(6): 627-631.
[5]	倪松平, 华孝真, 张素春. 2型糖尿病和妊娠期糖尿病对新生儿呼吸窘迫综合征的影响[J]. 中国儿童保健杂志, 2022, 30(4): 450-453.
[6]	惠晓君, 齐玉敏, 王品, 陈克云, 王岩. 支气管肺发育不良患儿重组人β防御素-2、血管新生相关基因对血管生成的调控机制及与肺发育标志物相关性[J]. 中国儿童保健杂志, 2022, 30(3): 325-329.
[7]	陈祥菲, 曲书强. 生物标志物在支气管肺发育不良发生风险中的研究进展[J]. 中国儿童保健杂志, 2022, 30(2): 176-180.
[8]	李尚彬, 郝玲, 李娇, 孟金凤, 黄嘉瑜, 闫伟宸, 王杰, 任常军. 极低和超低出生体重儿颅内出血危险因素Meta分析[J]. 中国儿童保健杂志, 2022, 30(2): 184-188.
[9]	高瑞, 李丛, 高玲玲, 韩梅盈, 许平. 极低出生体重儿和/或胎龄小于32周早产儿入院低体温发生的危险因素分析[J]. 中国儿童保健杂志, 2022, 30(2): 199-202.
[10]	游芳, 孔庆平, 强光峰, 赵静, 任雪云. 维生素D水平与极低出生体重儿临床结局的相关性研究[J]. 中国儿童保健杂志, 2022, 30(2): 216-220.
[11]	徐儒政, 孙斌. 动态分析生长发育迟缓与支气管肺发育不良严重程度的关系[J]. 中国儿童保健杂志, 2021, 29(6): 660-664.
[12]	董梦园, 吉玲, 刘萌萌, 朱逍帆, 王慧娟. 呼吸窘迫综合征早产儿发生支气管肺发育不良的危险因素分析[J]. 中国儿童保健杂志, 2021, 29(6): 685-688.
[13]	李倩倩, 姜泓. 维生素A与新生儿呼吸系统疾病关系的研究进展[J]. 中国儿童保健杂志, 2021, 29(5): 523-526.
[14]	张成强, 陆澄秋, 钱蓓倩, 张彬, 汪吉梅. 早产儿脐血血清25羟维生素D与呼吸窘迫综合征的关联性研究[J]. 中国儿童保健杂志, 2021, 29(5): 555-559.
[15]	彭倩, 曲书强. 肺微生物群落对早产儿肺发育影响的研究进展[J]. 中国儿童保健杂志, 2021, 29(3): 289-291.